Ironwood Cancer & Research Centers

Clinical research site in Glendale, Arizona · Ironwood Cancer & Research Centers, 5810 W Beverly Ln, Glendale, AZ 85306 · (623) 312-3000 · Website

Part of Ironwood Cancer & Research Centers

As of July 2026, 6 paid clinical trials are recruiting at Ironwood Cancer & Research Centers in Glendale, Arizona. Active studies at this site cover conditions such as Advanced Non-Small Cell Lung Cancer, Breast Cancer and Carcinoma, Non-Small-Cell Lung. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Ironwood Cancer & Research Centers (6)

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Advanced Non-Small Cell Lung Cancer

186 locations incl. Bullhead City

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for Intestinal Neoplasms

166 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for Breast Cancer

102 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for Metastatic Castration-Resistant Prostate Cancer

44 locations incl. Chandler

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT06629779·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for Metastatic Breast Cancer

73 locations incl. Chandler

Sponsor: American Society of Clinical Oncology

Sex: All·Age: 65+

Code: NCT06377852·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

More research sites in Glendale

Palo Verde Hematology Oncology (5 trials)
Sun City Clinical Research (4 trials)
Midwestern University Eye Institute (3 trials)
AARA Clinical Research (2 trials)
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Glendale (2 trials)
Arizona Arthritis & Rheumatology Associates (AARA) - Glendale (2 trials)
Valley Perinatal (2 trials)
Advanced Research Associates - Glendale (2 trials)
89bio Clinical Study Site (1 trial)
AARA Arizona Arthritis & Rheumatology Associates, P.C. - Glendale (1 trial)

Explore more

Paid clinical trials in Glendale, AZ · Arizona clinical trials